“From light bulbs, dental fillings and mascara to toxic toys, we all suffer from everyday exposure to dangerous toxic metals," said Isaac Eliaz, M.D., L.Ac., M.S. and the lead researcher of the study. “This report of five case studies confirms that modified citrus pectin combined with alginates is both safe and effective and has been proven to significantly address toxic heavy metal burden in patients with a number of different health conditions. The new clinical results can truly impact what is believed to be an epidemic of toxic pollution of the body with heavy metals.”

Using modified citrus pectin combined with alginates evolved out of successful clinical trials of Modified Citrus Pectin (MCP) alone, after it had proved effective in selectively removing toxic metals and (most importantly) not affecting the body’s essential minerals. MCP and alginates (derived from kelp seaweed) is an improved formulation for a more effective binding and removal of toxic metals, without side effects and the risk of toxin re-absorption and redistribution in the body. The clinical study was performed at the Amitabha Medical Clinic in the San Francisco Bay Area.

The five cases reported in the published study include:

1. A 59-year old male with a prostate cancer diagnosis and a suspected history of metal toxicity began a combined regimen of MCP treatment including modified citrus pectin combined with alginates. At three months, his lead level decreased 49 percent. His PSA dropped from 102 to <0.1, where it has remained over 18 months. No adverse effects were reported.

2. A 64-year old female with potential toxic metal exposure and a history of anxiety and depression began treatment with modified citrus pectin combined with alginates. At two months her lead levels decreased by 100 percent and her mercury levels decreased by 83 percent. Her symptoms improved during treatment and she reports that they remain resolved. No adverse effects were reported.

3. A 67-year old male with a 25 year history of prostatitis and prostate enlargement (including frequency and discomfort) and other symptoms including fatigue, chronic loose stool, asthma and allergies began treatment with modified citrus pectin combined with alginates. At nine months his mercury levels reduced by 80 percent. During this time his symptoms also stabilized dramatically resulting in regular bowel movements, an improvement in asthma and allergies and a PSA drop from 5.5 to 3.84. No adverse effects were reported.

4. A 45-year old male with symptoms of adrenal fatigue (including low cortisol levels, non-restorative sleep, and inability to gain weight) began treatment with modified citrus pectin combined with alginates. At seven months, his mercury levels dropped by 58 percent. He has since gained 10 pounds and experienced marked improvements in energy and sleeping patterns. No adverse effects were reported.

5. A 57-year old male with suspected mercury exposure and a decade-long history of headaches, constipation, IBS, elevated liver enzymes and a family history of Alzheimer’s disease began treatment with MCP after 12 months, his mercury levels were reduced by 73 percent and his symptoms subsided. No adverse effects were reported.

Better Health Publishing, founded by Isaac Eliaz, M.D. is a publishing house that focuses on the publication of key works promoting health and wellness. The staff at Better Health Publishing believes that a natural and efficacious lifestyle is the cornerstone of a return to healthy and sustainable society. The works published by BHP strive to promote this concept and disseminate to the public a healthier choice.

The modified citrus pectin combined with alginates used in the study was PectaSol® Chelation Complex. PectaSol® is a registered trademark of EcoNugenics, Inc., Santa Rosa, California.